The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $17.48 billion in 2025 to $18.88 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to recurring outbreaks of viral infections, expansion of clinical diagnostic laboratories, increased adoption of PCR-based testing, rising demand for early disease detection, improvements in laboratory infrastructure.
The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $24.87 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing preparedness for future pandemics, growing demand for decentralized testing, rising investments in molecular diagnostics, expansion of home-based testing solutions, technological advancements in assay sensitivity and speed. Major trends in the forecast period include increasing adoption of rapid diagnostic test kits, rising use of molecular-based viral detection, growing demand for point-of-care testing solutions, expansion of multiplex viral assay development, enhanced focus on high-sensitivity diagnostic accuracy.
The increasing prevalence of viral infections is expected to drive the growth of the viral diagnostic test kits market in the coming years. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can result in symptoms ranging from mild illness to severe, life-threatening conditions. The rise in viral infections is influenced by factors such as global travel, urbanization, unsafe injection practices, and limited access to timely diagnosis and treatment. Viral diagnostic test kits, which detect viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood or swabs, play a crucial role in identifying infections, guiding treatment decisions, and controlling outbreaks. For example, in April 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported 2,214 new acute hepatitis B cases in 2023, corresponding to an estimated 14,400 infections after accounting for underreporting, along with 17,650 newly reported chronic hepatitis B cases. The same report also recorded 4,966 new acute hepatitis C cases and 101,525 new chronic hepatitis C cases in 2023. Consequently, the growing prevalence of viral infections is fueling the viral diagnostic test kits market.
Leading companies in the viral diagnostic test kits market are focusing on developing innovative products, such as virus detection kits, to maintain their competitive edge. A virus detection kit is a diagnostic tool designed to detect specific viruses in biological samples, offering quick and accurate results to support effective disease monitoring and management. For example, in August 2024, BlueStain Global Ltd, a UK-based company, introduced the MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test that identifies the mpox virus with high speed and accuracy, providing results in just 15 to 30 minutes. This innovative kit aims to improve public health responses by enabling early detection and containment of mpox outbreaks, especially in resource-limited environments.
In June 2023, Avacta Life Sciences, a UK-based company in the life sciences sector, completed the acquisition of Coris Bioconcept for £7.4 million ($9.35 million). This strategic move by Avacta is aimed at bolstering its rapid diagnostic test portfolio, thereby strengthening its capabilities in healthcare diagnostics and expanding its market presence, particularly in the fields of infectious disease management and point-of-care testing. Coris Bioconcept, based in Belgium, specializes in the development and manufacturing of rapid diagnostic test kits, primarily focusing on lateral flow tests designed to detect viral and bacterial pathogens.
Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc.
North America was the largest region in the viral diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the viral diagnostic test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the viral diagnostic test kits market by increasing costs of imported reagents, enzymes, antibodies, plastic consumables, and analytical instruments required for molecular and rapid testing. Diagnostic laboratories and healthcare systems in North America and Europe are most affected due to dependence on global reagent supply chains, while Asia-Pacific faces pricing pressure on kit exports. These tariffs are raising test kit prices and affecting inventory planning. However, they are also driving domestic reagent manufacturing, regional production expansion, and strategic stockpiling initiatives to strengthen diagnostic supply chain resilience.
The viral diagnostic test kits market research report is one of a series of new reports that provides viral diagnostic test kits market statistics, including viral diagnostic test kits industry global market size, regional shares, competitors with a viral diagnostic test kits market share, detailed viral diagnostic test kits market segments, market trends and opportunities, and any further data you may need to thrive in the viral diagnostic test kits industry. This viral diagnostic test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Viral diagnostic test kits are instruments used in medicine to detect viral infections in clinical samples from patients. These kits typically contain reagents, antibodies, or other substances that interact with specific viral antigens or genetic material, generating a measurable signal. They can detect viral particles, antigens, or genetic material (such as RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.
The main types of viral diagnostic test kits include traditional tests and rapid tests. Traditional viral diagnostic tests are established laboratory-based methods that involve culturing the virus, detecting viral antigens, or measuring antibody responses. Examples of these tests include direct fluorescent antibody (DFA) tests, immunochromatographic assays, reverse transcriptase polymerase chain reaction (rt-PCR) based tests, agglutination assays, solid phase assays, flow through assays, and others. These tests are used by various end-users including research laboratories, clinics, hospitals, and others.
The viral diagnostic test kits market consists of sales of viral culture kits, molecular diagnostic kits, antibody detection kits, antigen detection kits, and multiplex PCR kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $24.87 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing preparedness for future pandemics, growing demand for decentralized testing, rising investments in molecular diagnostics, expansion of home-based testing solutions, technological advancements in assay sensitivity and speed. Major trends in the forecast period include increasing adoption of rapid diagnostic test kits, rising use of molecular-based viral detection, growing demand for point-of-care testing solutions, expansion of multiplex viral assay development, enhanced focus on high-sensitivity diagnostic accuracy.
The increasing prevalence of viral infections is expected to drive the growth of the viral diagnostic test kits market in the coming years. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can result in symptoms ranging from mild illness to severe, life-threatening conditions. The rise in viral infections is influenced by factors such as global travel, urbanization, unsafe injection practices, and limited access to timely diagnosis and treatment. Viral diagnostic test kits, which detect viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood or swabs, play a crucial role in identifying infections, guiding treatment decisions, and controlling outbreaks. For example, in April 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported 2,214 new acute hepatitis B cases in 2023, corresponding to an estimated 14,400 infections after accounting for underreporting, along with 17,650 newly reported chronic hepatitis B cases. The same report also recorded 4,966 new acute hepatitis C cases and 101,525 new chronic hepatitis C cases in 2023. Consequently, the growing prevalence of viral infections is fueling the viral diagnostic test kits market.
Leading companies in the viral diagnostic test kits market are focusing on developing innovative products, such as virus detection kits, to maintain their competitive edge. A virus detection kit is a diagnostic tool designed to detect specific viruses in biological samples, offering quick and accurate results to support effective disease monitoring and management. For example, in August 2024, BlueStain Global Ltd, a UK-based company, introduced the MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test that identifies the mpox virus with high speed and accuracy, providing results in just 15 to 30 minutes. This innovative kit aims to improve public health responses by enabling early detection and containment of mpox outbreaks, especially in resource-limited environments.
In June 2023, Avacta Life Sciences, a UK-based company in the life sciences sector, completed the acquisition of Coris Bioconcept for £7.4 million ($9.35 million). This strategic move by Avacta is aimed at bolstering its rapid diagnostic test portfolio, thereby strengthening its capabilities in healthcare diagnostics and expanding its market presence, particularly in the fields of infectious disease management and point-of-care testing. Coris Bioconcept, based in Belgium, specializes in the development and manufacturing of rapid diagnostic test kits, primarily focusing on lateral flow tests designed to detect viral and bacterial pathogens.
Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc.
North America was the largest region in the viral diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the viral diagnostic test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the viral diagnostic test kits market by increasing costs of imported reagents, enzymes, antibodies, plastic consumables, and analytical instruments required for molecular and rapid testing. Diagnostic laboratories and healthcare systems in North America and Europe are most affected due to dependence on global reagent supply chains, while Asia-Pacific faces pricing pressure on kit exports. These tariffs are raising test kit prices and affecting inventory planning. However, they are also driving domestic reagent manufacturing, regional production expansion, and strategic stockpiling initiatives to strengthen diagnostic supply chain resilience.
The viral diagnostic test kits market research report is one of a series of new reports that provides viral diagnostic test kits market statistics, including viral diagnostic test kits industry global market size, regional shares, competitors with a viral diagnostic test kits market share, detailed viral diagnostic test kits market segments, market trends and opportunities, and any further data you may need to thrive in the viral diagnostic test kits industry. This viral diagnostic test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Viral diagnostic test kits are instruments used in medicine to detect viral infections in clinical samples from patients. These kits typically contain reagents, antibodies, or other substances that interact with specific viral antigens or genetic material, generating a measurable signal. They can detect viral particles, antigens, or genetic material (such as RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.
The main types of viral diagnostic test kits include traditional tests and rapid tests. Traditional viral diagnostic tests are established laboratory-based methods that involve culturing the virus, detecting viral antigens, or measuring antibody responses. Examples of these tests include direct fluorescent antibody (DFA) tests, immunochromatographic assays, reverse transcriptase polymerase chain reaction (rt-PCR) based tests, agglutination assays, solid phase assays, flow through assays, and others. These tests are used by various end-users including research laboratories, clinics, hospitals, and others.
The viral diagnostic test kits market consists of sales of viral culture kits, molecular diagnostic kits, antibody detection kits, antigen detection kits, and multiplex PCR kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Viral Diagnostic Test Kits Market Characteristics
3. Viral Diagnostic Test Kits Market Supply Chain Analysis
4. Global Viral Diagnostic Test Kits Market Trends and Strategies
5. Viral Diagnostic Test Kits Market Analysis of End Use Industries
7. Global Viral Diagnostic Test Kits Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Viral Diagnostic Test Kits Total Addressable Market (TAM) Analysis for the Market
9. Viral Diagnostic Test Kits Market Segmentation
10. Viral Diagnostic Test Kits Market Regional and Country Analysis
11. Asia-Pacific Viral Diagnostic Test Kits Market
12. China Viral Diagnostic Test Kits Market
13. India Viral Diagnostic Test Kits Market
14. Japan Viral Diagnostic Test Kits Market
15. Australia Viral Diagnostic Test Kits Market
16. Indonesia Viral Diagnostic Test Kits Market
17. South Korea Viral Diagnostic Test Kits Market
18. Taiwan Viral Diagnostic Test Kits Market
19. South East Asia Viral Diagnostic Test Kits Market
20. Western Europe Viral Diagnostic Test Kits Market
21. UK Viral Diagnostic Test Kits Market
22. Germany Viral Diagnostic Test Kits Market
23. France Viral Diagnostic Test Kits Market
24. Italy Viral Diagnostic Test Kits Market
25. Spain Viral Diagnostic Test Kits Market
26. Eastern Europe Viral Diagnostic Test Kits Market
27. Russia Viral Diagnostic Test Kits Market
28. North America Viral Diagnostic Test Kits Market
29. USA Viral Diagnostic Test Kits Market
30. Canada Viral Diagnostic Test Kits Market
31. South America Viral Diagnostic Test Kits Market
32. Brazil Viral Diagnostic Test Kits Market
33. Middle East Viral Diagnostic Test Kits Market
34. Africa Viral Diagnostic Test Kits Market
36. Viral Diagnostic Test Kits Market Competitive Landscape and Company Profiles
37. Viral Diagnostic Test Kits Market Other Major and Innovative Companies
40. Viral Diagnostic Test Kits Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Viral Diagnostic Test Kits Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses viral diagnostic test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for viral diagnostic test kits? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral diagnostic test kits market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Testing Approach: Traditional Tests; Rapid Test2) By Test Type: Direct Fluorescent Antibody (DFA) Test; Immunochromatographic Assay; Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test; Agglutination Assay; Solid Phase Assay; Flow Through Assay; Other Test Types
3) By End-User: Research Laboratories; Clinics; Hospitals; Other End Users
Subsegments:
1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Polymerase Chain Reaction (PCR) Tests; Western Blot; Viral Culture Testing2) By Rapid Test: Lateral Flow Assays (LFA); Immunochromatographic Strip Tests; Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP); Rapid Antigen Tests
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; Quest Diagnostics Incorporated; Grifols S.A.; Hologic Inc.; PerkinElmer Inc.; bioMérieux SA; Quidel Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Ortho Clinical Diagnostics; Seegene Inc.; OraSure Technologies Inc.; Meridian Bioscience Inc.; DiaSorin S.p.A.; Trinity Biotech plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Viral Diagnostic Test Kits market report include:- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG
- Becton Dickinson and Company
- Quest Diagnostics Incorporated
- Grifols S.A.
- Hologic Inc.
- PerkinElmer Inc.
- bioMérieux SA
- Quidel Corporation
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Ortho Clinical Diagnostics
- Seegene Inc.
- OraSure Technologies Inc.
- Meridian Bioscience Inc.
- DiaSorin S.p.A.
- Trinity Biotech plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 18.88 Billion |
| Forecasted Market Value ( USD | $ 24.87 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
